Literature DB >> 114518

Laminin--a glycoprotein from basement membranes.

R Timpl, H Rohde, P G Robey, S I Rennard, J M Foidart, G R Martin.   

Abstract

We have isolated a large noncollagenous glycoprotein, laminin, from a mouse tumor that produces basement membrane. The protein consists of at least two polypeptide chains (Mr = 220,000 and Mr = 440,000) joined to each other by disulfide bonds. Laminin and type IV collagen are major constituents of the tumor. Laminin is distinctly different from fibronectin, another component of basement membranes, in amino acid composition and immunological reactivity. Pepsin digestion of laminin releases a large, cystine-rich fragment which retains most of the antigenicity of the original protein. Immunological studies using purified antibody against laminin show that it is produced by a variety of cultured cells. In addition, these antibodies react with the basement membranes of normal tissues, suggesting that this protein or an immunologically related protein is a constituent of the basement membranes of these tissues.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114518

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  537 in total

1.  A comparison of caveolae and caveolin-1 to folate receptor alpha in retina and retinal pigment epithelium.

Authors:  C C Bridges; A El-Sherbeny; P Roon; M S Ola; R Kekuda; V Ganapathy; R S Camero; P L Cameron; S B Smith
Journal:  Histochem J       Date:  2001-03

2.  The critical role of basement membrane-independent laminin gamma 1 chain during axon regeneration in the CNS.

Authors:  Barbara Grimpe; Sucai Dong; Catherine Doller; Katherine Temple; Alfred T Malouf; Jerry Silver
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

3.  An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.

Authors:  K Tashiro; A Monji; I Yoshida; Y Hayashi; K Matsuda; N Tashiro; Y Mitsuyama
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

4.  The behavior of the extracellular matrix and the basal lamina during the repair of cryogenic injury in the adult rat cerebral cortex.

Authors:  M Suzuki; B H Choi
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Cultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal.

Authors:  Hisatoshi Sugiura; Xiangde Liu; Fenghai Duan; Shin Kawasaki; Shinsaku Togo; Koichiro Kamio; Xing Qi Wang; Lijun Mao; Youngsoo Ahn; Ronald F Ertl; Tom W Bargar; Abdo Berro; Thomas B Casale; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

6.  Expression of laminin in benign and malignant sclerosing lesions of extrahepatic bile ducts.

Authors:  C Haglund; P J Roberts; S Nordling
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

7.  Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

Authors:  F Slowik; K Jellinger; L Gaszó; J Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants.

Authors:  A Albini; S L Aukerman; R C Ogle; D M Noonan; R Fridman; G R Martin; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

9.  Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.

Authors:  P M Zeltzer; S L Schneider; D D Von Hoff
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

10.  Laminin and vascular proliferation in rheumatoid arthritis.

Authors:  D L Scott; M Salmon; C J Morris; A C Wainwright; K W Walton
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.